Verrica Pharmaceuticals Inc share price logo

Verrica Pharmaceuticals Inc

NASDAQ: VRCA

Small Cap

$7.12

+0.76

(+12.03%)

as on

Verrica Pharmaceuticals Inc Stock Performance

as on May 6, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $6.38
    $7.20
    downward going graph

    10.39%

    Downside

    1.12%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $3.28
    $9.82
    downward going graph

    53.93%

    Downside

    37.94%

    Upside

    downward going graph

Verrica Pharmaceuticals Inc share price movements today

Previous Close
$6.36
Open
$6.39
Volume
212.0K
Day's Low - High
$6.38 - $7.20
52 Week Low - High
$3.28 - $9.82

Verrica Pharmaceuticals Inc Historical Returns

1 Month Return
+ 19.73 %
3 Month Return
+ 3.62 %
1 Year Return
+ 59.04 %
3 Year Return
-89.07 %
5 Year Return
-93.76 %

Verrica Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Verrica Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$123.0M

EPS (TTM)

-2.075

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-11.5M

Revenue (TTM)

35.6M

Profit Margin

-50.27%

Return On Equity TTM

-240.36%

Verrica Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Verrica Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$123.0M-93.76%NA-50.27%
BUY$40.2B127.94%75.8512.55%
BUY$107.9B99.08%25.1832.94%
NA$33.1BNA120.445.37%
BUY$73.6B40.83%17.1329.65%

Stock Returns calculator for Verrica Pharmaceuticals Inc Stock including INR - Dollar returns

The Verrica Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Verrica Pharmaceuticals Inc investment value today

Current value as on today

₹1,77,585

Returns

₹77,585

(+77.58%)

Returns from Verrica Pharmaceuticals Inc Stock

₹58,222 (+58.22%)

Dollar Impact

₹19,362 (+19.36%)

Analyst Recommendation on Verrica Pharmaceuticals Inc Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Verrica Pharmaceuticals Inc. Average target price of $16.5

Verrica Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Verrica Pharmaceuticals Inc.

What analysts predicted

56.85%UPSIDE

Target Price

$16.5

Current Price

$7.12

Analyzed by

12 Analysts

Target

$16.50

Verrica Pharmaceuticals Inc target price $16.5, a slight upside of 56.85% compared to current price of $7.12. According to 12 analysts rating.

Verrica Pharmaceuticals Inc Stock’s Investor Sentiment and Interest

Search interest for Verrica Pharmaceuticals Inc Stock has decreased by -31% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-31% versus previous 30 day period

Verrica Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
2
1
3
5
-1
0
3
12
14
5
Gross Profit
2
-18
2
4
-2
0
3
12
13
3
Operating Income
-23
-23
-18
-15
-20
-11
-8
1
1
-6
EBITDA
-22
-20
-17
-14
-20
-13
-7
2
2
-8
Interest Expense
1
2
2
2
2
2
2
2
2
1
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-24
-24
-20
-17
-22
-16
-9
0
0
-8
Income Tax Expense
0
0
0
-
0
0
-
-
-
-
Net Income
-24
-24
-20
-17
-22
-16
-9
0
0
-8
Net Profit Margin
-850.26%
-1238.13%
-531.39%
-331.97%
1283.55%
-4709.88%
-283.28%
1.61%
-1.91%
-158.56%

Verrica Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
12
12
9
5
7
35
Gross Profit
-
-
0
0
0
11
8
4
4
32
Operating Income
-1
-4
-21
-30
-40
-30
-21
-65
-65
-11
EBITDA
-1
-4
-20
-29
-39
-30
-21
-62
-65
-11
Interest Expense
-
0
-
-
3
4
2
3
9
7
Depreciation
-
-
0
0
0
0
0
0
1
0
Income Before Tax
-1
-4
-20
-28
-42
-35
-24
-66
-76
-17
Income Tax Expense
-1
-4
1
0
2
3
3
0
-
-
Net Income
-1
-4
-20
-27
-45
-35
-24
-66
-76
-17
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-379.14%
-292.33%
-271.11%
-1307.47%
-1012.15%
-50.27%

Verrica Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-24
-20
-17
-22
-16
-9
0
0
-8
Operating Cash Flow
-14
-19
-16
-8
-16
-12
-10
9
-4
Investing Cash Flow
0
-
0
0
0
-
-
-
-
Financing Cash Flow
0
0
0
0
39
-4
-4
-3
13
Change in Cash
-14
-20
-17
-8
23
-16
-14
5
9

Verrica Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-4
-20
-28
-42
-35
-24
-66
-76
-17
Operating Cash Flow
-4
-17
-27
-30
-27
-18
-38
-60
-17
Investing Cash Flow
-79
-79
25
-3
0
54
0
0
-
Financing Cash Flow
12
99
0
35
33
-16
74
37
1
Change in Cash
8
1
-1
1
5
18
35
-23
-16

Global Institutional Holdings in Verrica Pharmaceuticals Inc

Funds
Holdings
Caligan Partners LP
5.38%
Mariner Wealth Advisors LLC
0.15%
Goldman Sachs Group Inc
0.15%
Stonepine Capital Management Llc
2.06%
Beck, Mack & Oliver LLC
0.07%

Insights on Verrica Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, VRCA stock has moved up by 100.0%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, VRCA has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, VERRICA PHARMACEUTICALS INC has experienced a drawdown of -89.1%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 81.2%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 204.0K → -8.07M (in $), with an average decrease of 1540.5% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 14.34M → 5.09M (in $), with an average decrease of 64.5% per quarter

About Verrica Pharmaceuticals Inc

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The company offers YCANTH (VP-102) a drug-device combination that contains a GMP-controlled formulation of cantharidin for the treatment of molluscum in adult and pediatric patients, as well as for the treatment of common warts. It also develops VP-315, an oncolytic peptide-based injectable therapy that is in phase II clinical trial for the treatment of dermatology oncologic conditions, which include basal cell carcinoma and other dermatological oncology indications. The company has a collaboration and license agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum and common warts in Japan; and a license agreement with Lytix Biopharma AS to develop and commercialize VP-315 for use in malignant and pre-malignant dermatological indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.
OrganisationVerrica Pharmaceuticals Inc
Headquarters44 West Gay Street, West Chester, PA, United States, 19380
IndustryBiotechnology
CEODr. Jayson M. Rieger M.B.A., Ph.D.
E-voting on sharesClick here to vote

Key Management of Verrica Pharmaceuticals Inc

Name

Title

Dr. Jayson M. Rieger M.B.A., Ph.D.

President, CEO & Director

Mr. John J. Kirby CPA

Interim Chief Financial Officer

Dr. Noah L. Rosenberg M.D.

Chief Medical Officer

Mr. David Zawitz

COO, Chief Legal Officer & Secretary

Mr. Eugene Scavola

Executive Vice President of Technical Operations

Dr. Bradley J. Catalone MBA, Ph.D.

Head of Drug Development

Mr. Chris Chapman

Chief Commercial Officer

FAQs

What is Verrica Pharmaceuticals Inc share price today?

Verrica Pharmaceuticals Inc share price today is $7.12 as on at the close of the market. Verrica Pharmaceuticals Inc share today touched a day high of $7.2 and a low of $6.38.

What is the 52 week high and 52 week low for Verrica Pharmaceuticals Inc share?

Verrica Pharmaceuticals Inc share touched a 52 week high of $9.82 on and a 52 week low of $3.28 on . Verrica Pharmaceuticals Inc stock price today i.e. is closed at $7.12,which is 27.50% down from its 52 week high and 117.07% up from its 52 week low.

What is Verrica Pharmaceuticals Inc's market capitalisation today?

Verrica Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Verrica Pharmaceuticals Inc Stock (VRCA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Verrica Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Verrica Pharmaceuticals Inc Shares that will get you 0.2107 shares as per Verrica Pharmaceuticals Inc share price of $7.12 per share as on May 6, 2026 at 1:29 am IST.

What is the minimum amount required to buy Verrica Pharmaceuticals Inc Stock (VRCA) from India?

Indian investors can start investing in Verrica Pharmaceuticals Inc (VRCA) shares with as little as ₹94.61 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.10 in Verrica Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Verrica Pharmaceuticals Inc share’s latest price of $7.12 as on May 6, 2026 at 1:29 am IST, you will get 1.4045 shares of Verrica Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Verrica Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Verrica Pharmaceuticals Inc stock has given -93.76% share price returns and 28.83% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?